The highly anticipated Ingredient Idol competition at SupplySide Global 2026 concluded with the crowning of three groundbreaking ingredients, each securing top honors in their respective hot categories: adaptogens, biotics, and longevity. Held at the bustling SupplySide Global exhibition, the event saw a packed audience witness finalists passionately present their innovations, culminating in a decisive victory for Xeya Modern Shatavari, effera Lactoferrin, and Kinexa Joint Longevity Complex.
The prestigious competition, emceed by Devon Gholam, an editor at SupplySide Supplement Journal, showcased the vanguard of dietary supplement science. Each category featured three finalists, representing the forefront of innovation in trending health and wellness markets. While the audience’s enthusiastic applause offered an early indicator of public favor, the ultimate selection rested with a distinguished panel of industry expert judges: Diana Morgan, Doug Lynch, and David Foreman. Their collective expertise was instrumental in identifying the ingredients poised to make the most significant impact on the future of the supplement industry.
Adaptogen Champion: Xeya Modern Shatavari Pioneers Women’s Health Solutions
In a resounding victory that captured both the audience’s admiration and the judges’ approval, Xeya Modern Shatavari emerged as the undisputed winner in the adaptogen category. Manufactured by Laila Nutra and expertly distributed by NXT USA, this innovative ingredient marks a significant advancement in harnessing the power of traditional botanicals for modern health concerns.
Xeya Modern Shatavari is a highly standardized extract derived from the root of Asparagus racemosus, commonly known as shatavari. What sets this ingredient apart is its precisely calibrated concentration of 15% shatavarins, the active compounds believed to be responsible for its therapeutic benefits. Emerging research, including studies that have explored its efficacy in addressing the physiological challenges of perimenopause and polyendocrine metabolic ovarian syndrome (PMOS), highlights Xeya’s potential to offer targeted support. The ingredient’s ability to address hormonal balance and related symptoms positions it as a key player in the growing women’s health market, a segment experiencing unprecedented demand for scientifically validated natural solutions.
Todd Runestad, Chief Storytelling Officer at NXT USA, expressed his elation following the announcement, describing Xeya as a "hormonal adaptogen" with an exceptional potency. "It’s the lowest dose because it has the highest concentration of shatavarins," Runestad explained, emphasizing the ingredient’s versatility in various delivery formats, from capsules and powders to functional foods and beverages. This high concentration translates to greater bioavailability and efficacy, allowing for smaller, more palatable doses without compromising results. The adaptogen market, projected to reach over $20 billion globally by 2030 according to industry analysts, is increasingly seeking ingredients with robust clinical backing and demonstrable benefits, a niche Xeya Modern Shatavari appears well-positioned to fill. The ingredient’s dual win underscores its perceived value and potential market penetration.
Biotics Breakthrough: effera Lactoferrin Redefines Gut Health and Immunity
The biotics category saw Helaina’s effera Lactoferrin claim both the audience choice and top honors, signaling a significant leap forward in the application of bioidentical human lactoferrin. This innovative ingredient is poised to revolutionize the understanding and utilization of this vital protein in supporting gut health and immune function.
effera is a precision-fermented, bioidentical human lactoferrin, a naturally occurring glycoprotein found in human milk and other bodily secretions. Its presence in breast milk is crucial for infant development, providing essential antimicrobial, anti-inflammatory, and immune-modulating properties. Helaina’s breakthrough lies in its ability to replicate this human-identical molecule through advanced fermentation technology, making it accessible for broader use in dietary supplements and functional foods.
Preprint research on effera has provided compelling evidence of its multifaceted benefits. Studies indicate that effera plays a critical role in "strengthening the integrity of the gut epithelial barrier," a fundamental aspect of maintaining digestive health and preventing the passage of harmful substances into the bloodstream. Furthermore, an ex vivo adult model study demonstrated effera’s capacity to "support the gut microbiome and boost acetate production." Acetate, a short-chain fatty acid (SCFA), is vital for colonocyte energy, immune regulation, and overall gut health. The ability of effera to enhance SCFA production suggests a significant impact on the gut ecosystem, contributing to a more balanced and resilient microbiome.
Dan DeMarino, VP of Commercial at Helaina, articulated the profound implications of their innovation, stating, "We are at a new frontier in human health. We have precision fermentation and we have the ability to make human bioactives that we didn’t have access to before." This sentiment highlights the paradigm shift effera represents, moving beyond traditional probiotic and prebiotic approaches to offer a human-identical bioactive with a scientifically validated mechanism of action. The biotics market, a rapidly expanding segment encompassing probiotics, prebiotics, and postbiotics, is increasingly demanding ingredients with robust scientific validation and demonstrable health outcomes. effera’s strong showing at Ingredient Idol suggests it is well-equipped to meet these evolving consumer and industry expectations, potentially capturing a significant share of the market focused on digestive wellness and immune support. The dual win further amplifies its perceived advantage in a competitive landscape.
Longevity Leader: Kinexa Joint Longevity Complex Targets Mobility and Well-being
In the highly competitive longevity category, Kinexa Joint Longevity Complex, developed by PLT Health Solutions, was awarded the prestigious Idol title by the expert judges. While all three finalists in this category achieved a tie in the audience choice vote, the judges’ decision underscored Kinexa’s compelling scientific foundation and its potential to address a key aspect of healthy aging: joint health.
Kinexa is a sophisticated botanical blend formulated with three powerful plant-derived ingredients known for their synergistic effects on joint function: turmeric (Curcuma longa), Indian frankincense (Boswellia serrata), and Haritaki (Terminalia chebula). This unique combination is designed to provide comprehensive support for joint health, addressing aspects such as stiffness, discomfort, and overall mobility.
The scientific backing for Kinexa is particularly noteworthy. Researchers have employed advanced imaging techniques, including magnetic resonance imaging (MRI), to demonstrate the extract’s efficacy. These studies have shown that the standardized extract significantly "improves knee strength and lessens stiffness and discomfort." While a clinical trial is currently pending publication, the preliminary findings presented at SupplySide Global generated considerable excitement within the industry. The ingredient’s ability to directly impact physical markers of joint health, such as strength and stiffness, positions it as a promising solution for individuals seeking to maintain an active and comfortable lifestyle as they age.
Jeremy Appleton, N.D., Director of Medical and Scientific Affairs at PLT Health Solutions, conveyed his vision for Kinexa’s impact, stating, "We really hope that Kinexa will change the conversation about what a longevity ingredient can deliver." This statement reflects a broader trend within the longevity market, which is moving beyond simple anti-aging claims to focus on promoting sustained vitality and functional independence. By targeting joint health, a critical component of mobility and quality of life, Kinexa addresses a fundamental need for aging populations worldwide. The global longevity market is expanding rapidly, with projections indicating substantial growth in the coming years, driven by an aging demographic and an increasing focus on preventative health measures. Kinexa’s scientific rigor and targeted approach make it a strong contender to capture a significant share of this burgeoning market.
A Platform for Innovation: SupplySide Global and Ingredient Idol
SupplySide Global serves as a premier international trade show dedicated to the health and nutrition industry. It provides a vital platform for ingredient manufacturers, suppliers, formulators, and brand owners to connect, discover new innovations, and gain insights into emerging market trends. The event facilitates collaboration, business development, and the advancement of scientific understanding within the supplement and functional food sectors.
The Ingredient Idol competition, a cornerstone event at SupplySide Global, has a well-established reputation for identifying and celebrating cutting-edge ingredients. The rigorous selection process, which involves expert judging and public engagement, ensures that the winning ingredients represent not only scientific merit but also market relevance and consumer appeal. Over the years, Ingredient Idol alumni have gone on to achieve significant commercial success, demonstrating the competition’s efficacy as a launchpad for innovation.
The 2026 edition of SupplySide Global, with its focus on adaptogens, biotics, and longevity, accurately reflects the current landscape of consumer demand and scientific inquiry. These categories are experiencing sustained growth, driven by increasing consumer awareness of the role of diet and supplements in managing stress, optimizing gut health, and promoting healthy aging. The success of Xeya Modern Shatavari, effera Lactoferrin, and Kinexa Joint Longevity Complex at Ingredient Idol signals their potential to shape the future of these critical health categories. The event’s ability to attract a standing-room-only audience for the final presentations further underscores the industry’s keen interest in novel ingredients that offer scientifically supported benefits and address unmet consumer needs.
The continued success of Ingredient Idol at SupplySide Global highlights the dynamic nature of the dietary supplement industry. It showcases a commitment to scientific rigor, innovation, and the development of ingredients that can positively impact global health and well-being. As these three winning ingredients move forward, their journey will be closely watched by the industry, potentially setting new benchmarks for efficacy, application, and market penetration in their respective fields.
